Cetaben-induced changes on the morphology and peroxisomal enzymes in MH1C1 rat hepatoma cells and HepG2 human hepatoblastoma cells

Histochemistry and Cell Biology

Volumn 115, Issue 6, 2001, Pages 509-519

  Kovacs, Werner ^a   Walter, Ingrid ^b   Stangl, Herbert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Cetaben; HepG2; MH1C1; Morphology; Peroxisome; Proliferation

Indexed keywords

ACYL COENZYME A OXIDASE; CATALASE; CETABEN; ENZYME; PEROXISOME PROLIFERATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOGENESIS; CANCER CELL CULTURE; CELL STRAIN; CELL STRAIN HEPG2; CELL STRUCTURE; CONTROLLED STUDY; DRUG RESPONSE; GENE EXPRESSION; GOLGI COMPLEX; HEPATOBLASTOMA; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MITOCHONDRION; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

ANIMALIA;

EID: 0034913236     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180100278     Document Type: Article

References (58)

1. Controlled synthesis of HBsAG in a differentiated human liver carcinoma-derived cell line
2. Selective cytochemical localization of peroxidase, cytochrome oxidase and catalase in rat liver with 3,3′-diaminobenzidine
3. Regulation of gene expression by fatty acids and fibric acid derivatives: An integrative role for PPARs
4. Tissue fractionation studies. In-tracellular distribution of monoamine oxidase, aspartate ami-notransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat liver tissue
5. Biogenesis of peroxisomes: Immunocytochemical investigation of peroxisomal membrane proteins in proliferating rat liver peroxisomes and in catalase-negative loops
6. Application of automatic image analysis for morphometric studies of peroxisomes stained cytochemically for catalase II. Light microscopic application
7. Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting
8. Cultured hepatocytes: A useful in vitro system to investigate effects induced by peroxisome proliferators and their species specificity
9. The effect of beclobric acid and clofibric acid on peroxisomalb-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes
10. Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients
11. Further cellular investigation of the human hepatoblastoma-derived cell line Hep G2: Morphology and immunocytochemical studies of hepatic-secreted proteins
12. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
13. Stimulation of peroxisomal palmitoyl-CoA oxidase activity by ciprofibrate in hepatic cell lines: Comparative studies in FaO, MH1C1 and HepG2 cells
14. Cetaben is an exceptional type of peroxi-some proliferator
15. Cetaben and fibrates both influence the activities of peroxisomal enzymes in different ways
16. Developmental cell death: Morphological diversity and multiple mechanisms
17. Peroxisomes (microbodies and related particles)
18. Peroxisome proliferation andb-oxidation in FaO and MH1C1 rat hepatoma cells. HepG2 human hepatoblastoma cells and cultured human hepatocytes: Effect of ciprofibrate
19. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
20. Cytochemical localization of catalase and peroxidase in sinusoidal cells of rat liver
21. Peroxisome proliferators as cytochrome P450 inducers
22. Biogenesis of peroxisomes: Intra-cellular site of synthesis of catalase and uricase
23. Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines
24. Peroxisomes in sebaceous glands. V. Complex peroxisomes in mouse preputial gland: Serial sectioning and three-dimensional reconstruction studies
25. The central executioners of apopto-sis: Caspases or mitochondria?
26. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man
27. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney
28. Clofibrate does not induce peroxisomal proliferation in human hepatoma cell lines PLC/PRF/5 and SK-HEP-1
29. HepG2 cells as a resource for metabolic studies: Lipoprotein, cholesterol and bile acids
30. Localization of mRNAs encoding peroxisomal proteins in cell culture by non-radioactive in situ hybridization. Comparison of rat and human hepatoma cells and their response to two divergent hypolipidemic drugs
31. Cell compartmentalization of cholesterol biosynthesis
32. Peroxisome proliferation: Current mechanisms relating to nongenotoxic carcinogenesis
33. Different chain length specifities of peroxisomal and mitochondrial enoyl-CoA hydratases
34. Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
35. Immunocytochemical localization of peroxisomal enzymes in human liver biopsies
36. Complete nucleotide sequence of cDNA and predicted amino acid sequence of rat acyl-CoA oxidase
37. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
38. Studies on microperoxisomes. V. Are microperoxisomes ubiquitous in mammalian cells?
39. Purification and properties of acyl-CoA oxidase from rat liver
40. Peroxisome proliferator activated receptor-alpha expression in human liver
41. Peroxisome proliferator-induced pleiotropic responses: Pursuit of a phenomenon
42. Peroxisomal lipid metabolism
43. Establishment of a clonal strain of hepatoma cells which secrete albumin
44. Heterogeneity of catalase staining in human hepatocellular peroxisomes
45. Nonradioactive in situ hybridization for detection of mRNAs encoding for peroxisomal proteins: Heterogeneous hepatic lobular distribution after treatment with a single dose of bezafibrate
46. Role of the peroxisome proliferator activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
47. Heterogeneity for peroxisomes in human hepatoblastoma bell line HepG2. Evidence of distinct subpopulations
48. Interaction of microtubules with peroxisomes. Tubular and spherical peroxisomes in HepG2 cells and their alterations induced by microtubule-active drugs
49. Comparative effects of clofibrate on peroxisomal enzymes of human (Hep EBNA2) and rat (FaO) hepatoma cell lines
50. Effects of the rodent peroxisome proliferator and hepatocar-cinogen, perfluorooctanoic acid, on apoptosis in human hepa-toma HepG2 cells
51. Differential induction of peroxisomal enzymes by hypolipidaemics in human (HepG2) and rat (MH1C1) hepatoma cell lines
52. Peroxisomes: Simple in function but complex in maintenance
53. Peroxisome proliferator-activated receptors: Structures and function
54. Biochemistry of peroxisomes
55. Role and organization of peroxisomal beta-oxidation
56. Lipid metabolism in peroxisomes: Enzymology, functions and dysfunctions of the fatty acid alpha- and beta-oxidation systems in humans
57. Effect of the hypolipidemic drug RMI 14,514 on hepatic ultrastructure of rats
58. Cytochemical and immunocytochemical study on the peroxisomes of rat liver after administration of a hypolipidemic drug. MLM-160